XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2021
Jun. 30, 2021
Current assets    
Cash and cash equivalents $ 192 $ 319
Receivables, net 569 604
Inventories, net 818 752
Prepaid expenses and other current assets 162 154
Total current assets 1,741 1,829
Property, plant and equipment, net of accumulated depreciation and amortization of $2,466 and $2,382, respectively 1,298 1,302
Operating lease right-of-use assets 310 332
Goodwill 1,565 1,575
Trademarks, net 690 693
Other intangible assets, net 210 225
Other assets 376 378
Total assets 6,190 6,334
Current liabilities    
Notes and loans payable 383 0
Current maturities of long-term debt 600 300
Current operating lease liabilities 73 81
Accounts payable and accrued liabilities 1,540 1,675
Total current liabilities 2,596 2,056
Long-term debt 1,886 2,484
Long-term operating lease liabilities 286 301
Other liabilities 861 834
Deferred income taxes 70 67
Total liabilities 5,699 5,742
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of December 31, 2021 and June 30, 2021; and 122,964,541 and 122,780,220 shares outstanding as of December 31, 2021 and June 30, 2021, respectively 131 131
Additional paid-in capital 1,180 1,186
Retained earnings 949 1,036
Treasury stock, at cost: 7,776,920 and 7,961,241 shares as of December 31, 2021 and June 30, 2021, respectively (1,373) (1,396)
Accumulated other comprehensive net (loss) income (574) (546)
Total Clorox stockholders’ equity 313 411
Noncontrolling interests 178 181
Total stockholders’ equity 491 592
Total liabilities and stockholders’ equity $ 6,190 $ 6,334